• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

WaveLight signs agreement with Oculus to market Oculyzer pentacam

Article

WaveLight Inc. announced a joint agreement with German-based Oculus GmbH to sell the Oculus Pentacam under the brand name Oculyzer in conjunction with the Allegretto Wave family of products.

Chicago-WaveLight Inc. announced a joint agreement with German-based Oculus GmbH to sell the Oculus Pentacam under the brand name Oculyzer in conjunction with the Allegretto Wave family of products.

WaveLight will now offer two topography-guided systems, both of which are manufactured by Oculus. The Allegro Topolyzer produces eight reproducible topographic maps and delivers customized Allegretto Wave treatments through its T-CAT diagnostic interface. The Allegro Oculyzer features a wider array of diagnostic capabilities than the Topolyzer, including a Scheimpflug camera that provides five critical measurements of the anterior segment of the eye, as well as detailed central corneal data. It is also designed to be integrated with the Allegretto Wave through its exclusive OcuLink software interface.

The Oculyzer will be available for sale internationally in 2006, with the addition of the OcuLink anticipated in late spring. The agreement between WaveLight and Oculus will also permit the Oculyzer to be sold as a diagnostic tool for U.S. customers. While U.S. clinical studies have not been initiated using the Oculyzer, the company said it is planning to commence topography-guided clinical trials with the Topolyzer system soon.

More information is available at the WaveLight Booth 3250.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.